Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global Viral Vector-Based Gene Therapy Drugs Market Research Report 2024
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Retroviral Vector
1.2.3 Adenovirus Vector
1.2.4 Lentiviral Vector
1.2.5 Others
1.3 Market by Application
1.3.1 Global Viral Vector-Based Gene Therapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector-Based Gene Therapy Drugs Market Perspective (2019-2030)
2.2 Global Viral Vector-Based Gene Therapy Drugs Growth Trends by Region
2.2.1 Global Viral Vector-Based Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector-Based Gene Therapy Drugs Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector-Based Gene Therapy Drugs Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector-Based Gene Therapy Drugs Market Dynamics
2.3.1 Viral Vector-Based Gene Therapy Drugs Industry Trends
2.3.2 Viral Vector-Based Gene Therapy Drugs Market Drivers
2.3.3 Viral Vector-Based Gene Therapy Drugs Market Challenges
2.3.4 Viral Vector-Based Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector-Based Gene Therapy Drugs Players by Revenue
3.1.1 Global Top Viral Vector-Based Gene Therapy Drugs Players by Revenue (2019-2024)
3.1.2 Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector-Based Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector-Based Gene Therapy Drugs Revenue
3.4 Global Viral Vector-Based Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global Viral Vector-Based Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector-Based Gene Therapy Drugs Revenue in 2023
3.5 Global Key Players of Viral Vector-Based Gene Therapy Drugs Head office and Area Served
3.6 Global Key Players of Viral Vector-Based Gene Therapy Drugs, Product and Application
3.7 Global Key Players of Viral Vector-Based Gene Therapy Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector-Based Gene Therapy Drugs Breakdown Data by Type
4.1 Global Viral Vector-Based Gene Therapy Drugs Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector-Based Gene Therapy Drugs Forecasted Market Size by Type (2025-2030)
5 Viral Vector-Based Gene Therapy Drugs Breakdown Data by Application
5.1 Global Viral Vector-Based Gene Therapy Drugs Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector-Based Gene Therapy Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector-Based Gene Therapy Drugs Market Size (2019-2030)
6.2 North America Viral Vector-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
6.4 North America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector-Based Gene Therapy Drugs Market Size (2019-2030)
7.2 Europe Viral Vector-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.4 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector-Based Gene Therapy Drugs Market Size (2019-2030)
9.2 Latin America Viral Vector-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
9.4 Latin America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Viral Vector-Based Gene Therapy Drugs Introduction
11.1.4 GSK Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.1.5 GSK Recent Development
11.2 MolMed
11.2.1 MolMed Company Details
11.2.2 MolMed Business Overview
11.2.3 MolMed Viral Vector-Based Gene Therapy Drugs Introduction
11.2.4 MolMed Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.2.5 MolMed Recent Development
11.3 GILD
11.3.1 GILD Company Details
11.3.2 GILD Business Overview
11.3.3 GILD Viral Vector-Based Gene Therapy Drugs Introduction
11.3.4 GILD Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.3.5 GILD Recent Development
11.4 JW Therapeutics
11.4.1 JW Therapeutics Company Details
11.4.2 JW Therapeutics Business Overview
11.4.3 JW Therapeutics Viral Vector-Based Gene Therapy Drugs Introduction
11.4.4 JW Therapeutics Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.4.5 JW Therapeutics Recent Development
11.5 Sibiono
11.5.1 Sibiono Company Details
11.5.2 Sibiono Business Overview
11.5.3 Sibiono Viral Vector-Based Gene Therapy Drugs Introduction
11.5.4 Sibiono Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.5.5 Sibiono Recent Development
11.6 Latima
11.6.1 Latima Company Details
11.6.2 Latima Business Overview
11.6.3 Latima Viral Vector-Based Gene Therapy Drugs Introduction
11.6.4 Latima Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.6.5 Latima Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Viral Vector-Based Gene Therapy Drugs Introduction
11.7.4 Novartis Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Viral Vector-Based Gene Therapy Drugs Introduction
11.8.4 Bluebird Bio Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.8.5 Bluebird Bio Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Introduction
11.9.4 Thermo Fisher Scientific Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Intas
11.10.1 Intas Company Details
11.10.2 Intas Business Overview
11.10.3 Intas Viral Vector-Based Gene Therapy Drugs Introduction
11.10.4 Intas Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.10.5 Intas Recent Development
11.11 BMS
11.11.1 BMS Company Details
11.11.2 BMS Business Overview
11.11.3 BMS Viral Vector-Based Gene Therapy Drugs Introduction
11.11.4 BMS Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.11.5 BMS Recent Development
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Introduction
11.12.4 Orchard Therapeutics Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.12.5 Orchard Therapeutics Recent Development
11.13 Shanghai Sunway Biotech
11.13.1 Shanghai Sunway Biotech Company Details
11.13.2 Shanghai Sunway Biotech Business Overview
11.13.3 Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Introduction
11.13.4 Shanghai Sunway Biotech Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.13.5 Shanghai Sunway Biotech Recent Development
11.14 uniQure
11.14.1 uniQure Company Details
11.14.2 uniQure Business Overview
11.14.3 uniQure Viral Vector-Based Gene Therapy Drugs Introduction
11.14.4 uniQure Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.14.5 uniQure Recent Development
11.15 Spark Therapeutics
11.15.1 Spark Therapeutics Company Details
11.15.2 Spark Therapeutics Business Overview
11.15.3 Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Introduction
11.15.4 Spark Therapeutics Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
11.15.5 Spark Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global Viral Vector-Based Gene Therapy Drugs Market Research Report 2024
List of TablesTable 1. Global Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Retroviral Vector
Table 3. Key Players of Adenovirus Vector
Table 4. Key Players of Lentiviral Vector
Table 5. Key Players of Others
Table 6. Global Viral Vector-Based Gene Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Viral Vector-Based Gene Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Viral Vector-Based Gene Therapy Drugs Market Share by Region (2019-2024)
Table 10. Global Viral Vector-Based Gene Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Viral Vector-Based Gene Therapy Drugs Market Share by Region (2025-2030)
Table 12. Viral Vector-Based Gene Therapy Drugs Market Trends
Table 13. Viral Vector-Based Gene Therapy Drugs Market Drivers
Table 14. Viral Vector-Based Gene Therapy Drugs Market Challenges
Table 15. Viral Vector-Based Gene Therapy Drugs Market Restraints
Table 16. Global Viral Vector-Based Gene Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Viral Vector-Based Gene Therapy Drugs Market Share by Players (2019-2024)
Table 18. Global Top Viral Vector-Based Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector-Based Gene Therapy Drugs as of 2023)
Table 19. Ranking of Global Top Viral Vector-Based Gene Therapy Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Viral Vector-Based Gene Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Viral Vector-Based Gene Therapy Drugs, Headquarters and Area Served
Table 22. Global Key Players of Viral Vector-Based Gene Therapy Drugs, Product and Application
Table 23. Global Key Players of Viral Vector-Based Gene Therapy Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Viral Vector-Based Gene Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Viral Vector-Based Gene Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. GSK Company Details
Table 49. GSK Business Overview
Table 50. GSK Viral Vector-Based Gene Therapy Drugs Product
Table 51. GSK Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 52. GSK Recent Development
Table 53. MolMed Company Details
Table 54. MolMed Business Overview
Table 55. MolMed Viral Vector-Based Gene Therapy Drugs Product
Table 56. MolMed Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 57. MolMed Recent Development
Table 58. GILD Company Details
Table 59. GILD Business Overview
Table 60. GILD Viral Vector-Based Gene Therapy Drugs Product
Table 61. GILD Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 62. GILD Recent Development
Table 63. JW Therapeutics Company Details
Table 64. JW Therapeutics Business Overview
Table 65. JW Therapeutics Viral Vector-Based Gene Therapy Drugs Product
Table 66. JW Therapeutics Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 67. JW Therapeutics Recent Development
Table 68. Sibiono Company Details
Table 69. Sibiono Business Overview
Table 70. Sibiono Viral Vector-Based Gene Therapy Drugs Product
Table 71. Sibiono Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 72. Sibiono Recent Development
Table 73. Latima Company Details
Table 74. Latima Business Overview
Table 75. Latima Viral Vector-Based Gene Therapy Drugs Product
Table 76. Latima Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 77. Latima Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Viral Vector-Based Gene Therapy Drugs Product
Table 81. Novartis Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Bluebird Bio Company Details
Table 84. Bluebird Bio Business Overview
Table 85. Bluebird Bio Viral Vector-Based Gene Therapy Drugs Product
Table 86. Bluebird Bio Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 87. Bluebird Bio Recent Development
Table 88. Thermo Fisher Scientific Company Details
Table 89. Thermo Fisher Scientific Business Overview
Table 90. Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Product
Table 91. Thermo Fisher Scientific Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 92. Thermo Fisher Scientific Recent Development
Table 93. Intas Company Details
Table 94. Intas Business Overview
Table 95. Intas Viral Vector-Based Gene Therapy Drugs Product
Table 96. Intas Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 97. Intas Recent Development
Table 98. BMS Company Details
Table 99. BMS Business Overview
Table 100. BMS Viral Vector-Based Gene Therapy Drugs Product
Table 101. BMS Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 102. BMS Recent Development
Table 103. Orchard Therapeutics Company Details
Table 104. Orchard Therapeutics Business Overview
Table 105. Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Product
Table 106. Orchard Therapeutics Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 107. Orchard Therapeutics Recent Development
Table 108. Shanghai Sunway Biotech Company Details
Table 109. Shanghai Sunway Biotech Business Overview
Table 110. Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Product
Table 111. Shanghai Sunway Biotech Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 112. Shanghai Sunway Biotech Recent Development
Table 113. uniQure Company Details
Table 114. uniQure Business Overview
Table 115. uniQure Viral Vector-Based Gene Therapy Drugs Product
Table 116. uniQure Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 117. uniQure Recent Development
Table 118. Spark Therapeutics Company Details
Table 119. Spark Therapeutics Business Overview
Table 120. Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Product
Table 121. Spark Therapeutics Revenue in Viral Vector-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 122. Spark Therapeutics Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Viral Vector-Based Gene Therapy Drugs Picture
Figure 2. Global Viral Vector-Based Gene Therapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Viral Vector-Based Gene Therapy Drugs Market Share by Type: 2023 VS 2030
Figure 4. Retroviral Vector Features
Figure 5. Adenovirus Vector Features
Figure 6. Lentiviral Vector Features
Figure 7. Others Features
Figure 8. Global Viral Vector-Based Gene Therapy Drugs Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Viral Vector-Based Gene Therapy Drugs Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Diagnostic and Testing Laboratories Case Studies
Figure 12. Academic and Research Organizations Case Studies
Figure 13. Others Case Studies
Figure 14. Viral Vector-Based Gene Therapy Drugs Report Years Considered
Figure 15. Global Viral Vector-Based Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Viral Vector-Based Gene Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Viral Vector-Based Gene Therapy Drugs Market Share by Region: 2023 VS 2030
Figure 18. Global Viral Vector-Based Gene Therapy Drugs Market Share by Players in 2023
Figure 19. Global Top Viral Vector-Based Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector-Based Gene Therapy Drugs as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Viral Vector-Based Gene Therapy Drugs Revenue in 2023
Figure 21. North America Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Viral Vector-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 23. United States Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Viral Vector-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 27. Germany Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Viral Vector-Based Gene Therapy Drugs Market Share by Region (2019-2030)
Figure 35. China Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Viral Vector-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 43. Mexico Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 47. Turkey Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Viral Vector-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. GSK Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 51. MolMed Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 52. GILD Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 53. JW Therapeutics Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 54. Sibiono Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 55. Latima Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 56. Novartis Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 57. Bluebird Bio Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 59. Intas Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 60. BMS Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 61. Orchard Therapeutics Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 62. Shanghai Sunway Biotech Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 63. uniQure Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 64. Spark Therapeutics Revenue Growth Rate in Viral Vector-Based Gene Therapy Drugs Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
REQUEST COMPANIES MENTIONED IN THIS REPORT
